What is the electrophysiological mechanism underlying the short‑long‑short sequence of premature ventricular contractions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Short-Long-Short Electrophysiological Mechanism

The short-long-short (SLS) sequence is a pause-dependent arrhythmogenic mechanism where a premature ventricular contraction (short interval) is followed by a compensatory pause (long interval), which then triggers another premature beat (short interval) that initiates ventricular tachyarrhythmias, most characteristically torsades de pointes in long QT syndrome. 1

Core Electrophysiological Mechanism

The SLS sequence operates through triggered activity from early afterdepolarizations (EADs) that occur during the prolonged action potential following the pause 2. Here's how it unfolds algorithmically:

The Three-Step Sequence:

  1. First "Short": A premature ventricular contraction occurs with a relatively short coupling interval to the preceding beat

  2. "Long": This creates a compensatory pause, during which:

    • Action potential duration becomes markedly prolonged
    • The membrane remains depolarized longer than normal
    • Repolarizing potassium currents are reduced
    • Inward calcium currents or late sodium currents increase 2
  3. Second "Short": During this prolonged repolarization phase, EADs develop when:

    • L-type calcium channels reactivate before the membrane returns to normal resting potential
    • Spontaneous calcium release from the sarcoplasmic reticulum activates depolarizing sodium-calcium exchange currents 2
    • This generates the triggering PVC that initiates the arrhythmia

Disease-Specific Patterns

The SLS mechanism manifests differently across conditions:

Long QT Syndrome: This is the classic setting where SLS sequences predominate. Recent data shows that 54% of ventricular fibrillation episodes in LQTS patients are initiated by SLS sequences, with trigger coupling intervals exceeding 450 ms in 68% of cases 3. The guideline explicitly states that torsades de pointes "often has a long-short initiating sequence with a long coupling interval to the first VT beat" 1.

Bradycardia-Related: High-grade AV block can create the prolonged pauses necessary for SLS sequences, facilitating torsades de pointes 1. This is particularly relevant when backup pacing rates are programmed too low (e.g., 35 bpm), which may inadvertently create the substrate for SLS-triggered arrhythmias 4.

Clinical Implications and Pitfalls

ICD Programming Considerations:

A critical pitfall occurs with single-chamber ICDs using combined onset and stability criteria. The SLS sequence can prevent appropriate therapy delivery because the varying cycle lengths fail to meet onset detection thresholds, even during sustained VT 4. The initial short-long transition creates rate variability that the device misinterprets as non-ventricular in origin.

To prevent this:

  • Avoid requiring both onset AND stability criteria simultaneously
  • Lower VT detection rates appropriately (e.g., from 160 to 150 bpm)
  • Increase backup pacing rates from very low settings (35 bpm) to at least 55 bpm to prevent pause-dependent triggers 4

Autonomic Nervous System Role:

Variable coupling intervals in PVCs—which characterize SLS sequences—have particularly destabilizing effects on the intrinsic cardiac nervous system. Variable coupling intervals affect convergent neurons (local reflex processors) more than fixed intervals, creating both neuronal and electrical instability 5. This suggests the SLS pattern is not merely a trigger but actively destabilizes cardiac control mechanisms.

Substrate Requirements

For SLS sequences to successfully trigger sustained arrhythmias, there must be:

  • Temporal dispersion: The prolonged action potential creates heterogeneous repolarization across the myocardium 2
  • Spatial substrate: Regions of structural or functional heterogeneity that allow small clusters of triggered cells to overcome source-sink mismatch 6
  • Adequate trigger strength: The second "short" beat must generate sufficient current to depolarize surrounding tissue

The mechanism differs fundamentally from reentrant VT, which requires both a trigger and a structural substrate with an excitable gap 2. In contrast, SLS-triggered arrhythmias depend on abnormal impulse formation rather than abnormal impulse propagation.

References

Research

Distinct patterns of ventricular fibrillation onset in primary electrical diseases: insights from a retrospective multicentre registry.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025

Related Questions

In a short‑long‑short pattern, is the first beat a sinus beat, the second beat a premature ventricular contraction (PVC), and the third beat a sinus beat?
What are the electrophysiological mechanisms underlying premature ventricular contractions (PVCs) in a non‑ischemic heart?
When should torsades de pointes be treated with electrical shock and what are the recommended energy settings?
Is torsades de pointes a shockable rhythm?
Can norepinephrine (Levophed) be used instead of isoproterenol to treat bradycardia that is precipitating or threatening torsades de pointes?
If topiramate causes excessive sedation for migraine prophylaxis, what alternative medication can be used?
In an elderly male with Alzheimer disease, insomnia, elevated cholesterol, chronic renal disease, dysphagia, hiatal hernia, and orthostasis who is currently taking escitalopram 20 mg daily, mirtazapine 15 mg nightly, melatonin 5 mg at bedtime, and gabapentin 200 mg three times daily, and who presents with restlessness, agitation, non‑compliance, fecal smearing, disrobing, and aggression, what non‑pharmacologic strategies and medication adjustments are recommended to safely manage his agitation?
After being off Adderall (amphetamine/dextroamphetamine) for one week, can the patient restart at a dose of 20 mg?
What are the side effects of divalproex sodium and the optimal evening dosing time for a migraine patient who must awaken at 4:30 am for work?
In a patient with known vestibular migraine on sumatriptan who presents with vertigo, headache, photophobia and phonophobia but no focal neurological deficits or red‑flag signs, is a CT scan required to rule out a brain mass?
Should a patient who develops chronic bile‑acid diarrhea after cholecystectomy be maintained on bile‑acid sequestrant therapy lifelong?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.